TY - JOUR T1 - Group 5 drugs for multidrug-resistant tuberculosis: is the glass half full or half empty? JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02273-2016 VL - 49 IS - 1 SP - 1602273 AU - Giovanni Sotgiu AU - Giovanni Battista Migliori Y1 - 2017/01/01 UR - http://erj.ersjournals.com/content/49/1/1602273.abstract N2 - The 2016 World Health Organization (WHO) tuberculosis (TB) report, published after the approval of the End TB Strategy, shows that, because of the improved surveillance/survey figures from India, the global 2015 TB incidence and mortality reached 10.4 and 1.4 million, respectively [1–5]. Together with India, China, Nigeria, Pakistan, Indonesia, Pakistan and South Africa contribute most to the global TB burden.Coordinated effort in the fight against MDR-TB is needed to develop new drugs and better use existing ones http://ow.ly/bsxD306sPsw ER -